Clinical trial

Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

NCT00595504

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-01-01

PhasePHASE4

Study timeline

Study start (unknown)2008-01-01Date precision: month

Registry last updated2012-09-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disordersunresolved

Interventions

RamelteonDRUG · verified · RxNorm: ramelteon

PlaceboDRUG

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

Takedacollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00595504 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.